Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | UBASH3B | Q8TF42 | 1/20 | 1.00 |
| ▸ | PPARG | P37231 | 1/20 | 0.55 |
| ▸ | ITGB2 | P05107 | 6/20 | 0.55 |
| ▸ | ICAM1 | P05362 | 6/20 | 0.55 |
| ▸ | ITGAL | P20701 | 6/20 | 0.55 |
| ▸ | F11 | P03951 | 2/20 | 0.54 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.54 |
| ▸ | TACR1 | P25103 | 2/20 | 0.52 |
| ▸ | CCKBR | P32239 | 1/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Rebamipide SCHEMBL21623658 | 1.00 | UBASH3B (1.00) | UBASH3BPPARGITGB2ICAM1ITGAL | |
| Rebamipide SCHEMBL29560992 | 1.00 | UBASH3B (1.00) | UBASH3BPPARGITGB2ICAM1ITGAL | |
| Rebamipide SCHEMBL23346201 | 1.00 | UBASH3B (1.00) | UBASH3BPPARGITGB2ICAM1ITGAL | |
| Rebamipide SCHEMBL5794018 | 1.00 | UBASH3B (1.00) | UBASH3BPPARGITGB2ICAM1ITGAL | |
| Rebamipide SCHEMBL9114879 | 0.99 | UBASH3B (0.98) | UBASH3BPPARGITGB2ICAM1ITGAL | |
| Rebamipide SCHEMBL28798513 | 0.99 | UBASH3B (0.98) | UBASH3BPPARGITGB2ICAM1ITGAL | |
| Rebamipide SCHEMBL27819911 | 0.99 | UBASH3B (0.98) | UBASH3BPPARGITGB2ICAM1ITGAL | |
| Rebamipide SCHEMBL2292009 | 0.99 | UBASH3B (0.98) | UBASH3BPPARGITGB2ICAM1ITGAL | |
| Rebamipide SCHEMBL26607917 | 0.99 | UBASH3B (0.98) | UBASH3BPPARGITGB2ICAM1ITGAL | |
| Rebamipide SCHEMBL27858766 | 0.99 | UBASH3B (0.98) | UBASH3BPPARGITGB2ICAM1ITGAL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 4619 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122075220-A | Contact lens for treating xerophthalmia and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-121574094-B | Rebamipide Fu Nuola raw salt and preparation method and application thereof | 湖南先施制药有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-122031407-A | Rebamipide tablet and preparation method thereof | 泰州市第四人民医院 | 2026-05-15 | — | — | CN | claimed |
| WO-2026100654-A1 | NUCLEIC ACID INTRODUCTION AID, NUCLEIC ACID INTRODUCTION AGENT, AND NUCLEIC ACID INTRODUCTION METHOD | 株式会社インファーマシア | 2026-05-15 | — | — | WO | claimed |
| US-20260102359-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | ERESINA LLC (US) | 2026-04-16 | — | — | US | claimed |
| US-20260078448-A1 | METHODS OF DETECTING SJÖGREN'S SYNDROME USING SALIVARY EXOSOMES | EXOSOME DIAGNOSTICS INC (US) | 2026-03-19 | — | — | US | claimed |
| CN-121574094-A | Rebamipide Fu Nuola raw salt and preparation method and application thereof | 湖南先施制药有限公司 | 2026-02-27 | — | — | CN | claimed |
| US-12478627-B2 | Irsogladine for the treatment of eosinophilic gastrointestinal diseases | EPITHELION SCIENCE BIOTECH, S.L. (ES) | 2025-11-25 | — | — | US | claimed |
| EP-4593859-A1 | COMBINATION TREATMENT OF DERMAL AND TRANSDERMAL FIBROTIC DISEASES, DISORDERS AND ASSOCIATED PAIN AND INFLAMMATION | Eresina, LLC (US) | 2025-08-06 | — | — | EP | claimed |
| US-12370140-B2 | Micelle for solubilizing a sparingly water-soluble ingredient and solution comprising the same | TEIKA PHARMACEUTICAL CO., LTD. (JP) | 2025-07-29 | — | — | US | claimed |
| US-5480891-A | CARBOSTYRIL DERIVATIVES, NON-INSULIN DEPENDENT | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1996-01-02 | — | — | US | claimed |
| US-5476858-A | Treats esophagitis, alzheimer's disease, hepatitis, and acromegalia | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-12-19 | — | — | US | claimed |
| EP-0674515-A1 | CARBOSTYRIL DERIVATIVE FOR INHIBITING PRODUCTION OF INTERLEUKIN-8 | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-10-04 | — | — | EP | claimed |
| WO-1995012579-A1 | BISMUTH SALT OF CARBOSTYRIL DERIVATIVES FOR THE TREATMENT OF PEPTIC ULCERS | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1995-05-11 | — | — | WO | claimed |
| WO-1995011026-A1 | CARBOSTYRIL DERIVATIVE FOR INHIBITING PRODUCTION OF INTERLEUKIN-8 | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-04-27 | — | — | WO | claimed |
| EP-0621782-A1 | AGENT FOR PREVENTING AND TREATING DISTURBANCES OF INTESTINAL MUCOUS MEMBRANE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-11-02 | — | — | EP | claimed |
| WO-1994012182-A1 | AGENT FOR PREVENTING AND TREATING DISTURBANCES OF INTESTINAL MUCOUS MEMBRANE | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-06-09 | — | — | WO | claimed |
| EP-0594867-A1 | AGENT FOR INCREASING SOMATOSTATIN OR FOR INHIBITING DECREASE OF SOMATOSTATIN | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1994-05-04 | — | — | EP | claimed |
| WO-1993023043-A1 | AGENT FOR INCREASING SOMATOSTATIN OR FOR INHIBITING DECREASE OF SOMATOSTATIN | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1993-11-25 | — | — | WO | claimed |
| EP-0543018-A1 | Antidiabetic agent | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-05-26 | — | — | EP | claimed |